Search research articles
Contact Us
Filters
Showing results (11-20 of 199) with videos related to
Page
of 20
Sort By:
Epidemiology and Psychiatric Sciences
|
February 8, 2013
Drug treatments for schizophrenia: pragmatism in trial design shows lack of progress in drug design
F Cheng, P B Jones
Journal of Steroid Biochemistry
|
November 1, 1981
Regulation of ovarian 20 alpha-hydroxysteroid dehydrogenase by gonadotropin releasing hormone and its antagonist in vitro and in vivo
P B Jones, A J Hsueh
Psychological Medicine
|
November 27, 1999
Early risk factors and adult person--environment relationships in affective disorder
J Van Os, P B Jones
Clinical Science (London, England : 1979)
|
April 1, 1983
Effect of aspirin on urinary excretion of 6-ketoprostaglandin F1 alpha
P B Jones, R G Russell
Endocrinology
|
May 1, 1982
Regulation of ovarian 3 beta-hydroxysteroid dehydrogenase activity by gonadotropin-releasing hormone and follicle-stimulating hormone in cultured rat granulosa cells
P B Jones, A J Hsueh
Endocrinology
|
November 1, 1981
Regulation of progesterone-metabolizing enzyme by adrenergic agents, prolactin, and prostaglandins in cultured rat ovarian granulosa cells
P B Jones, A J Hsueh
The Medical Journal of Australia
|
May 26, 1984
Scalp cooling and cytotoxic drugs
J Dixon-Hughes, P B Jones
Psychological Medicine
|
August 13, 2013
Parity of esteem begins at home: translating empirical psychiatric research into effective public mental health
J B Kirkbride, P B Jones
Endocrine Reviews
|
January 1, 1981
Extrapituitary actions of gonadotropin-releasing hormone
A J Hsueh, P B Jones
Advances in Experimental Medicine and Biology
|
January 1, 1982
Regulation of ovarian granulosa and luteal cell functions by gonadotropin releasing hormone and its antagonist
A J Hsueh, P B Jones
Page
of 20
Search research articles
Search
Showing results (11-20 of 199) with videos related to
Sort By:
Page
of 20
Epidemiology and Psychiatric Sciences
|
February 8, 2013
Drug treatments for schizophrenia: pragmatism in trial design shows lack of progress in drug design
F Cheng, P B Jones
Journal of Steroid Biochemistry
|
November 1, 1981
Regulation of ovarian 20 alpha-hydroxysteroid dehydrogenase by gonadotropin releasing hormone and its antagonist in vitro and in vivo
P B Jones, A J Hsueh
Psychological Medicine
|
November 27, 1999
Early risk factors and adult person--environment relationships in affective disorder
J Van Os, P B Jones
Clinical Science (London, England : 1979)
|
April 1, 1983
Effect of aspirin on urinary excretion of 6-ketoprostaglandin F1 alpha
P B Jones, R G Russell
Endocrinology
|
May 1, 1982
Regulation of ovarian 3 beta-hydroxysteroid dehydrogenase activity by gonadotropin-releasing hormone and follicle-stimulating hormone in cultured rat granulosa cells
P B Jones, A J Hsueh
Endocrinology
|
November 1, 1981
Regulation of progesterone-metabolizing enzyme by adrenergic agents, prolactin, and prostaglandins in cultured rat ovarian granulosa cells
P B Jones, A J Hsueh
The Medical Journal of Australia
|
May 26, 1984
Scalp cooling and cytotoxic drugs
J Dixon-Hughes, P B Jones
Psychological Medicine
|
August 13, 2013
Parity of esteem begins at home: translating empirical psychiatric research into effective public mental health
J B Kirkbride, P B Jones
Endocrine Reviews
|
January 1, 1981
Extrapituitary actions of gonadotropin-releasing hormone
A J Hsueh, P B Jones
Advances in Experimental Medicine and Biology
|
January 1, 1982
Regulation of ovarian granulosa and luteal cell functions by gonadotropin releasing hormone and its antagonist
A J Hsueh, P B Jones
Page
of 20